US healthcare giant Abbott is expanding Glucerna-REX into the consumer market. With 17.6 g of carbohydrates per 200 ml, it has a low-carb formulation and has obtained the Locabo Mark. It is also expected to be adopted in specific health guidance programs provided by health insurers.
US-headquartered Abbott is broadly expanding Glucerna-REX, a food with nutrient function claims in its Glucerna line of disease-specific nutrition products, into the consumer market as well. The product is characterized by its low carbohydrate content and is expected to gain acceptance among consumers seeking to control their carbohydrate intake.
Product information publicly states that its carbohydrate content is 17.6 g per 200 ml, highlighting its low-carb formulation. The product is also introduced as having obtained the Locabo Mark, which promotes health and weight management.
Glucerna-REX is expected to be adopted in an increasing number of cases as one of the specific health guidance programs offered by health insurance societies. Although it has a 25-year sales track record with medical institutions, its expanding presence in the consumer market is drawing attention.